NCT00332228View on ClinicalTrials.gov

Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Opiate Dependence
Interventions
DRUG

depot naltrexone

long-acting depot parenteral formulation of naltrexone

BEHAVIORAL

Compliance enhancement (CE)

Compliance enhancement (CE), simulating standard treatment with oral naltrexone

DRUG

BNT

behavioral therapy with oral naltrexone maintenance for the treatment of heroin addiction

Trial Locations (2)

10032

New York State Psychiatric Institute, New York

STARS, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00332228 - Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence | Biotech Hunter | Biotech Hunter